Finastelad Driada Medical

£35.00

Finastelad by Driada Medical is a pharmaceutical-grade finasteride compound for laboratory research investigating 5-alpha reductase inhibition pathways and androgen metabolism studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Finastelad Driada Medical
Finastelad Driada Medical
£35.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Finastelad Driada Medical: Compound Profile

Finastelad by Driada Medical is a pharmaceutical-grade finasteride compound extensively studied for its selective inhibition of 5-alpha reductase type II enzyme activity. This steroid 5α-reductase inhibitor demonstrates potent enzymatic blockade, preventing the conversion of testosterone to dihydrotestosterone (DHT) in cellular research models. Laboratory investigations examine finasteride’s mechanism of competitive enzyme inhibition and its effects on androgen metabolism pathways. Researchers at Stroid UK Shop utilise this compound to study hormonal regulation mechanisms and steroid biochemistry in controlled experimental conditions.

Laboratory Applications

Scientific studies investigate finasteride’s role as a Type II 5α-reductase inhibitor in androgenetic research protocols. The compound demonstrates selective enzyme inhibition properties, making it valuable for examining DHT-dependent cellular processes and hormone-sensitive tissue responses. Research applications include investigating prostate cell biology, hair follicle physiology, and sebaceous gland function in laboratory models. Studies within aromatase inhibitors and finasteride research examine the compound’s effects on androgen-responsive tissues and steroid hormone pathways. Additional research protocols compare finasteride’s selectivity against other enzyme inhibitors used in SARMs and peptides research for comprehensive hormonal studies.

Technical Specifications

Finastelad Research Compound Specifications
Parameter Value
CAS Number 98319-26-7
Molecular Formula C₂₃H₃₆N₂O₂
Molecular Weight 372.55 g/mol
Purity Verify with supplier
Storage Room temperature, dry environment
Mechanism Type II 5α-reductase inhibitor

Research Compliance

Finastelad is supplied exclusively for in-vitro laboratory research and analytical reference purposes. This compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure compliance with institutional guidelines and applicable regulations when conducting studies with this research chemical. All investigations should be performed by qualified personnel in appropriate laboratory facilities with proper safety protocols and waste disposal procedures.

Related